Logo

Natera Draws $8M From Credit Facility

Jun 14, 2016 | staff reporter

NEW YORK (GenomeWeb) – Natera has drawn $8 million from its credit facility under a credit line agreement with UBS Bank, the company reported this week in a filing with the US Securities Exchange Commission. The draw down will provide working capital for the firm to use on a temporary basis.

Natera has $700,000 remaining under the credit line that it expects to use to pay interest.

Also this week, Natera expanded its supply agreement with Illumina to include an agreement to develop oncology in vitro diagnostic tests on Illumina's instruments.

Filed under

Molecular Diagnostics
Business News
Sequencing
credit facility
Natera
Breaking News
The Scan

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.

Australian Survey Points to Public Support for Genetic Risk Disclosure in Relatives of At-Risk Individuals

A survey in the European Journal of Human Genetics suggests most adult Australians are in favor of finding out if a relative tests positive for a medically actionable genetic variant.

Study Links Evolution of Stony Coral Skeleton to Bicarbonate Transporter Gene

A PNAS paper focuses on a skeleton-related bicarbonate transporter gene introduced to stony coral ancestors by tandem duplication.

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.